Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Eli Lilly and Company
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT01824290
First received: April 1, 2013
Last updated: November 29, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2023
  Estimated Primary Completion Date: January 2021 (Final data collection date for primary outcome measure)